Susan A Kadlubar
Overview
Explore the profile of Susan A Kadlubar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
356
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stahr S, Runnells G, Rogers L, McElfish P, Kadlubar S, Su L
Transl Cancer Res
. 2022 Feb;
8(Suppl 4):S366-S377.
PMID: 35117114
Background: Physical activity has been identified as a modifiable risk factor for breast cancer. Varying definitions of physical activity have made the evaluation difficult to analyze. In a state with...
2.
Stahr S, Chiang T, Bauer M, Runnells G, Rogers L, Vi Do H, et al.
Expo Health
. 2021 Aug;
13(2):269-280.
PMID: 34337191
Both arsenic and cadmium are reported to be toxic to humans. The use of saliva as a biomarker of low-level exposures to these elements has not been adequately explored, and...
3.
Hernandez Puente C, Hsu P, Rogers L, Jousheghany F, Siegel E, Kadlubar S, et al.
Front Oncol
. 2020 Jun;
10:879.
PMID: 32582547
Immune response to a given antigen, particularly in cancer patients, is complex and is controlled by various genetic and environmental factors. Identifying biomarkers that can predict robust response to immunization...
4.
Hsu P, Kadlubar S, Siegel E, Rogers L, Todorova V, Su L, et al.
PLoS One
. 2020 Apr;
15(4):e0230248.
PMID: 32298288
ClinicalTrials.gov Identifier: NCT00203502.
5.
McElfish P, Su L, Lee J, Runnells G, Henry-Tillman R, Kadlubar S
Breast Cancer (Auckl)
. 2019 Oct;
13:1178223419876296.
PMID: 31579384
Objectives: Rural women are underrepresented in cancer research. We hypothesized that providing access to a research study to rural, medically underserved women who were receiving their breast cancer screening using...
6.
McElfish P, Rowland B, Riklon S, Aitaoto N, Sinclair K, Ima S, et al.
Policy Polit Nurs Pract
. 2019 Sep;
20(4):205-215.
PMID: 31537196
The purpose of this study was to (a) describe the development of a culturally appropriate glucose monitoring video using a community-based participatory research approach and (b) assess the cultural appropriateness...
7.
Larsen V, Barlow W, Yang J, Zhu Q, Liu S, Kwan M, et al.
Clin Breast Cancer
. 2019 Apr;
19(4):225-235.e2.
PMID: 30928413
Introduction: GATA3 is a critical transcription factor in maintaining the differentiated state of luminal mammary epithelial cells. We sought to determine the prognostic and predictive roles of GATA3 genotypes for...
8.
Knox B, Wang Y, Rogers L, Xuan J, Yu D, Guan H, et al.
Environ Mol Mutagen
. 2017 Dec;
59(2):134-143.
PMID: 29205500
The transporter associated with antigen processing 2 (TAP2) is involved in the development of multidrug resistance and the etiology of immunological diseases. In this study, we investigated whether the expression...
9.
Tibbs Z, Guidry A, Falany J, Kadlubar S, Falany C
Xenobiotica
. 2017 Jan;
48(1):79-88.
PMID: 28084139
1. Human cytosolic sulfotransferase 1B1 (SULT1B1) sulfates small phenolic compounds and bioactivates polycyclic aromatic hydrocarbons. To date, no SULT1B1 allelic variants have been well-characterized. 2. While cloning SULT1B1 from human...
10.
Makhoul I, Todorova V, Siegel E, Erickson S, Dhakal I, Raj V, et al.
PLoS One
. 2017 Jan;
12(1):e0168550.
PMID: 28045923
Background: We previously reported improved pathologic complete response (pCR) in a prospective phase II study using neoadjuvant bevacizumab in combination with chemotherapy compared to chemotherapy alone in breast cancer patients...